Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease

• Status: Terminated
• Trial end date: 2013-11-01
• Target enrollment: 0
• Participant gender: All

Summary

Triptolide has been approve effective in animal model.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Zhi-Hong Liu, M.D.
• Treatments: Emodin; Triptolide

Criteria

Inclusion Criteria:

• Clinically established ADPKD

• eGFR>30ml/min.

• Chinese nationality

Exclusion Criteria:

• Uncontrolled infections

• Non-ADPKD complications